Grail, Inc. (NASDAQ:GRAL - Get Free Report)'s stock price dropped 6.6% on Monday . The company traded as low as $27.66 and last traded at $28.28. Approximately 214,893 shares traded hands during mid-day trading, a decline of 80% from the average daily volume of 1,050,701 shares. The stock had previously closed at $30.28.
Analyst Upgrades and Downgrades
A number of research analysts have commented on GRAL shares. Guggenheim started coverage on shares of Grail in a research report on Thursday, October 17th. They set a "neutral" rating on the stock. Morgan Stanley initiated coverage on shares of Grail in a report on Wednesday, November 27th. They set an "equal weight" rating and a $16.00 price objective on the stock. Finally, Wolfe Research started coverage on Grail in a report on Friday, November 15th. They set a "peer perform" rating for the company.
View Our Latest Stock Report on Grail
Grail Stock Performance
The business has a 50-day moving average of $21.12 and a two-hundred day moving average of $16.93.
Grail (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The company reported ($3.94) earnings per share for the quarter. The firm had revenue of $28.65 million for the quarter. On average, equities analysts expect that Grail, Inc. will post -65.16 EPS for the current year.
Insiders Place Their Bets
In other Grail news, CFO Aaron Freidin sold 30,452 shares of the firm's stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $14.02, for a total value of $426,937.04. Following the completion of the sale, the chief financial officer now owns 268,277 shares of the company's stock, valued at approximately $3,761,243.54. This trade represents a 10.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Hedge Funds Weigh In On Grail
Hedge funds have recently modified their holdings of the stock. FNY Investment Advisers LLC purchased a new stake in Grail during the 4th quarter worth approximately $26,000. Lindbrook Capital LLC acquired a new stake in shares of Grail during the fourth quarter worth $28,000. New York State Common Retirement Fund purchased a new stake in shares of Grail during the fourth quarter valued at $59,000. Wilmington Savings Fund Society FSB acquired a new position in shares of Grail in the 4th quarter valued at $64,000. Finally, Manchester Capital Management LLC purchased a new position in Grail in the 4th quarter worth $123,000.
Grail Company Profile
(
Get Free Report)
GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.
See Also
Before you consider Grail, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Grail wasn't on the list.
While Grail currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
